Stockpicker Comparison Tool
Nothing here is comparable yet for these companies.
Revenue Growth
HAE
5.60%
▲ 0.83%
XRAY
-4.06%
▼ -4.17%
Gross Margin
HAE
59.76%
▲ 2.53%
XRAY
54.90%
▲ 6.38%
Free Cash Flow
HAE
$44.42M
▼ -$8.86M
XRAY
$55.00M
▲ $67.00M
Net Debt / EBITDA
HAE
3.64
▲ 0.15
XRAY
12.05
▲ 28.91
Operating Margin
HAE
16.93%
▲ 2.08%
XRAY
9.13%
▲ 5.72%
P/E Ratio
HAE
40.05
▲ 11.76
XRAY
18.36
▲ 1.03